BioCardia, Inc. (BCDA) stock
BCDANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.83−0.10 (-10.38%)
Close on Nov 12, 2026Market cap $12.50MP/E –Yield –
BioCardia total assets
Total assets on the balance sheet at the end of each period.
BioCardia's total assets was $3.07M at Sep 30, 2026. For fiscal 2025 it was $3.41M, down 8.4% from the year before. Over ten years it grew -3.5% a year on average. The highest annual figure on record is $23.42M in fiscal 2020.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.41M | -8.4% |
| FY2024 | Dec 31, 2024 | $3.72M | +24.7% |
| FY2023 | Dec 31, 2023 | $2.99M | -69.5% |
| FY2022 | Dec 31, 2022 | $9.79M | -37.7% |
| FY2021 | Dec 31, 2021 | $15.72M | -32.9% |
| FY2020 | Dec 31, 2020 | $23.42M | +205.1% |
| FY2019 | Dec 31, 2019 | $7.68M | +19.7% |
| FY2018 | Dec 31, 2018 | $6.42M | -52.6% |
| FY2017 | Dec 31, 2017 | $13.54M | -38.7% |
| FY2016 | Dec 31, 2016 | $22.08M | +354.2% |
| FY2015 | Dec 31, 2015 | $4.86M | -65.0% |
| FY2014 | Dec 31, 2014 | $13.88M | +2.4% |
| FY2013 | Dec 31, 2013 | $13.55M | +1.8% |
| FY2012 | Dec 31, 2012 | $13.30M | -3.2% |
| FY2011 | Dec 31, 2011 | $13.73M | +152.7% |
| FY2010 | Dec 31, 2010 | $5.44M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $3.07M | -50.0% |
| Q2 FY2026 | Jun 30, 2026 | $4.76M | +127.6% |
| Q1 FY2026 | Mar 31, 2026 | $1.71M | -21.0% |
| Q4 FY2025 | Dec 31, 2025 | $3.41M | -8.4% |
| Q3 FY2025 | Sep 30, 2025 | $6.15M | -1.9% |
| Q2 FY2025 | Jun 30, 2025 | $2.09M | -27.7% |
| Q1 FY2025 | Mar 31, 2025 | $2.17M | -19.1% |
| Q4 FY2024 | Dec 31, 2024 | $3.72M | +24.7% |
| Q3 FY2024 | Sep 30, 2024 | $6.27M | +67.3% |
| Q2 FY2024 | Jun 30, 2024 | $2.89M | -54.8% |
| Q1 FY2024 | Mar 31, 2024 | $2.68M | -62.4% |
| Q4 FY2023 | Dec 31, 2023 | $2.99M | -69.5% |
| Q3 FY2023 | Sep 30, 2023 | $3.75M | -59.2% |
| Q2 FY2023 | Jun 30, 2023 | $6.39M | -43.3% |
| Q1 FY2023 | Mar 31, 2023 | $7.13M | -44.5% |
| Q4 FY2022 | Dec 31, 2022 | $9.79M | -37.7% |
| Q3 FY2022 | Sep 30, 2022 | $9.18M | -47.0% |
| Q2 FY2022 | Jun 30, 2022 | $11.27M | -44.3% |
| Q1 FY2022 | Mar 31, 2022 | $12.84M | -44.9% |
| Q4 FY2021 | Dec 31, 2021 | $15.72M | -32.9% |
| Q3 FY2021 | Sep 30, 2021 | $17.33M | +82.4% |
| Q2 FY2021 | Jun 30, 2021 | $20.22M | +54.0% |
| Q1 FY2021 | Mar 31, 2021 | $23.31M | +431.7% |
| Q4 FY2020 | Dec 31, 2020 | $23.42M | +205.1% |
| Q3 FY2020 | Sep 30, 2020 | $9.50M | -11.0% |
| Q2 FY2020 | Jun 30, 2020 | $13.13M | +383.4% |
| Q1 FY2020 | Mar 31, 2020 | $4.38M | -15.0% |
| Q4 FY2019 | Dec 31, 2019 | $7.68M | +19.7% |
| Q3 FY2019 | Sep 30, 2019 | $10.68M | +92.2% |
| Q2 FY2019 | Jun 30, 2019 | $2.72M | -64.5% |
| Q1 FY2019 | Mar 31, 2019 | $5.16M | -50.5% |
| Q4 FY2018 | Dec 31, 2018 | $6.42M | -52.6% |
| Q3 FY2018 | Sep 30, 2018 | $5.56M | -65.0% |
| Q2 FY2018 | Jun 30, 2018 | $7.66M | -56.9% |
| Q1 FY2018 | Mar 31, 2018 | $10.41M | -47.4% |
| Q4 FY2017 | Dec 31, 2017 | $13.54M | -38.7% |
| Q3 FY2017 | Sep 30, 2017 | $15.86M | – |
| Q2 FY2017 | Jun 30, 2017 | $17.76M | – |
| Q1 FY2017 | Mar 31, 2017 | $19.78M | – |
| Q4 FY2016 | Dec 31, 2016 | $22.08M | – |
See a number that looks wrong?